India is close to finishing an investigation into a complaint that a state drug regulator helped switch samples of cough syrups linked to the deaths of children in Gambia before they were tested in India. The World Health Organization (WHO) linked the syrups made by India's Maiden Pharmaceuticals to the deaths of 70 children in the African country last year. India's government says tests at an Indian government laboratory showed the syrups were not toxic.
